Aandeel A246960 SCL SCIENCE INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen SCL Science Inc.

Aandelen

A246960

KR7246960009

slotkoers Korea S.E.
Andere beurzen
 00:00:00 03-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8.730 KRW +0,69% Intraday-grafiek van SCL Science Inc. -0,80% -1,58%
2023 Lee Moon Su voltooide de overname van een belang van 98,04% in NVC 2019 Bio Health Care Investment Association van InnoTherapy, Inc. (KOSDAQ:A246960) CI
2022 SCL Healthcare Co., Ltd. heeft de overname afgerond van 22,97% belang in InnoTherapy, Inc. (KOSDAQ:A246960) van Lee, Moon Soo. CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
H2U Corp. announced that it has received KRW 1.29506497 billion in funding from InnoTherapy, Inc.
H2U Corp. announced that it has received KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 5.9999961 billion in funding from Scl Holdings and another investor
Health to U Corporation announced that it has received funding from InnoTherapy, Inc.
H2U Corp. announced that it expects to receive KRW 1.2171 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it expects to receive KRW 5.9999961 billion in funding
PhAST Corp. announced that it has received KRW 1.30609774 billion in funding from InnoTherapy, Inc.
Lee Moon Su completed the acquisition of a 98.04% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc.
Lee Moon Su agreed to acquire 98.039216% stake in NVC 2019 Bio Health Care Investment Association from InnoTherapy, Inc. for approximately KRW5 billion.
PhAST Corp. announced that it expects to receive KRW 1.30609774 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. announced that it has received KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
InnoTherapy, Inc. announced that it expects to receive KRW 4.999995 billion in funding from SCL Healthcare Co., Ltd., Seoul Clinical Laboratories
SCL Healthcare Co., Ltd. completed the acquisition of 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo.
SCL Healthcare Co., Ltd. agreed to acquire 22.97% stake in InnoTherapy, Inc. from Lee, Moon Soo for KRW 21.8 billion.
InnoTherapy, Inc. announced that it has received KRW 14.999868397 billion in funding from a group of investors
InnoTherapy, Inc. announced that it expects to receive KRW 7.5 billion in funding from Samsung Securities Co. Ltd., Investment Arm, KB Securities Co., Ltd., Korea Investment & Securities Co., Ltd., Investment Arm, Mirae Asset Daewoo Co., Ltd., Investment Arm, His-Story Investment Co.,Ltd., Shinhan Bank, Investment Arm, Shinhan Bank, Investment Arm, and Pureun Mutual Savings Bank Co., Ltd and another investor
InnoTherapy, Inc. cancelled the acquisition of 98.04% stake in NVC 2019 Bio Health Care Investment Association.
InnoTherapy, Inc. agreed to acquire 98.04% stake in NVC 2019 Bio Health Care Investment Association for KRW 5 billion.
NVC Partners announced that it has received KRW 1.1 billion in funding from InnoTherapy, Inc.
InnoTherapy, Inc. has completed an IPO in the amount of KRW 9 billion.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A246960
  4. Nieuws SCL Science Inc.
  5. Andere talen